SLC17A7 and Alzheimer disease: However, taken separately, or in linear combination using principal component analysis (PCA), the 7 markers for which a difference between groups was detected (VGLUT1, VIAAT, somatostatin, ChAT, α-tubulin, synaptophysin and PSD95) cannot be used as CDR markers in AD.